AR071550A1 - Uso de carbohidratos no digeribles para mejorar la microbiota intestinal - Google Patents

Uso de carbohidratos no digeribles para mejorar la microbiota intestinal

Info

Publication number
AR071550A1
AR071550A1 ARP080105631A ARP080105631A AR071550A1 AR 071550 A1 AR071550 A1 AR 071550A1 AR P080105631 A ARP080105631 A AR P080105631A AR P080105631 A ARP080105631 A AR P080105631A AR 071550 A1 AR071550 A1 AR 071550A1
Authority
AR
Argentina
Prior art keywords
oligosaccharides
composition
intestinal microbiota
carbohydrates
digerable
Prior art date
Application number
ARP080105631A
Other languages
English (en)
Inventor
Jan Knol
Amor Kaouther Ben
Der Beek Eline Marleen Van
Gelske Speelmans
Willem F Niewenhuizen
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40801379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR071550(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of AR071550A1 publication Critical patent/AR071550A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pediatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una composicion que comprende al menos dos carbohidratos no digeribles para suministrar y/o mantener una microbiota intestinal optima. La composicion es especialmente adecuada para la nutricion de lactantes. Reivindicacion 1: Uso de una composicion nutricional que comprende al menos dos carbohidratos no digeribles seleccionados del grupo que consiste en fructo-oligosacáridos, galacto-oligosacáridos, gluco-oligosacáridos, arabino-oligosacáridos, manano-oligosacáridos, xilo-oligosacáridos, fuco-oligosacáridos, arabinogalacto-oligosacáridos, glucomano-oligosacáridos, galactomano-oligosacáridos, oligosacáridos que comprenden ácido siálico y oligosacáridos de ácido uránico, caracterizado porque es para la fabricacion de una composicion para disminuir la relacion de Firmicutes/Bacteroidetes y/o Clostridium/Bacteroides en un sujeto humano hasta alcanzar la relacion hallada en sujetos humanos delgados saludables, y/o hasta alcanzar la relacion hallada en lactantes alimentados con leche materna, y/o respecto de la relacion presente en el sujeto humano antes de la ingestion de la composicion, y/o respecto de un grupo control que no toma la composicion.
ARP080105631A 2007-12-21 2008-12-19 Uso de carbohidratos no digeribles para mejorar la microbiota intestinal AR071550A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07124007 2007-12-21
US4078808P 2008-03-31 2008-03-31
EP08153775 2008-03-31

Publications (1)

Publication Number Publication Date
AR071550A1 true AR071550A1 (es) 2010-06-30

Family

ID=40801379

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080105631A AR071550A1 (es) 2007-12-21 2008-12-19 Uso de carbohidratos no digeribles para mejorar la microbiota intestinal
ARP080105632A AR077520A1 (es) 2007-12-21 2008-12-19 Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP080105632A AR077520A1 (es) 2007-12-21 2008-12-19 Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal

Country Status (8)

Country Link
US (2) US20110034407A1 (es)
EP (3) EP2589302B1 (es)
CN (2) CN101951794B (es)
AR (2) AR071550A1 (es)
ES (2) ES2611203T3 (es)
PL (2) PL2234505T3 (es)
RU (2) RU2478309C2 (es)
WO (2) WO2009082214A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9049881B2 (en) * 2009-08-18 2015-06-09 Nestec S.A. Nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
EP2514435A1 (en) * 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
WO2013032744A2 (en) 2011-08-17 2013-03-07 Nume Health, Llc Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum
JP5827519B2 (ja) * 2011-08-25 2015-12-02 株式会社ダイセル ペルオキシソーム増殖剤応答性受容体活性化剤
CN104039175A (zh) * 2011-10-24 2014-09-10 N·V·努特里奇亚 使用非消化性低聚糖的变态反应疗法
WO2013180747A2 (en) 2011-12-27 2013-12-05 Abbott Laboratories Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
WO2013111823A1 (ja) * 2012-01-25 2013-08-01 株式会社Ｊ－オイルミルズ スフィンゴイド塩基を含む抽出物の製造方法
AU2012369298B2 (en) * 2012-02-10 2016-02-25 N.V. Nutricia Maternal supplement to enhance immune system of an infant
WO2013126015A1 (en) * 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
SE536599C3 (sv) * 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014092564A1 (en) * 2012-12-10 2014-06-19 N.V. Nutricia Nutritional composition with non digestible oligosaccharides
US10028519B2 (en) 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
AU2015287703A1 (en) 2014-07-09 2017-02-16 Cadena Bio, Inc. Oligosaccharide compositions and methods for producing thereof
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
AU2016212030B2 (en) 2015-01-26 2021-06-17 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
ES2755042T3 (es) 2015-01-26 2020-04-21 Cadena Bio Inc Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
RU2017134547A (ru) * 2015-04-23 2019-04-09 Калейдо Байосайенсиз, Инк. Регуляторы микробиома и соответствующие варианты их применения
AU2016253010B2 (en) 2015-04-23 2021-06-10 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2017021476A1 (en) 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
WO2017084673A1 (en) * 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications
MX2018006295A (es) 2015-12-14 2018-08-16 Nestec Sa Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
WO2017103850A1 (en) 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
RU2735250C2 (ru) * 2016-01-26 2020-10-29 Сосьете Де Продюи Нестле С.А. КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP3493686B1 (en) * 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
EP3677273B1 (en) * 2017-08-29 2023-02-08 BGI Shenzhen Bacteroides cellulosityticus for use in preventing and/or treating atherosclerosis and obesity
TWI816735B (zh) * 2018-01-18 2023-10-01 日商朝日集團控股股份有限公司 酵母甘露聚糖之用途
CN111698993A (zh) * 2018-02-09 2020-09-22 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
EP3877424A2 (en) 2018-11-08 2021-09-15 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof
SG11202107687VA (en) 2019-01-18 2021-08-30 Cp Kelco U S Inc Prebiotic composition and its use
US20230046623A1 (en) * 2020-01-31 2023-02-16 N.V. Nutricia Nutritional composition for use in gut maturation
KR102236944B1 (ko) * 2020-04-29 2021-04-06 (주)네오크레마 갈락토올리고당, 또는 갈락토올리고당 및 콜라겐 트리펩타이드를 포함하는 면역기능 개선 및 피부상태 개선용 기능성 식품조성물 및 화장료 조성물
CN113476463A (zh) * 2021-07-13 2021-10-08 量子高科(广东)生物有限公司 一种益生元组合物及其应用
WO2024056784A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition
WO2024056786A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
JP3544493B2 (ja) * 1999-06-10 2004-07-21 雪印乳業株式会社 乳幼児用栄養組成物
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
EP1175905A1 (en) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
EP1438933B1 (de) * 2003-01-17 2005-04-06 WALDEMAR LINK GmbH & Co. KG Hüftprothese mit einem in den Markkanal des Oberschenkelknochens zu verankernden Schaft
NL1022443C2 (nl) * 2003-01-20 2004-07-22 Tno Sphingolipiden voor verbetering van de samenstelling van de darmflora.
WO2005035781A1 (en) * 2003-10-02 2005-04-21 Novartis Ag Prebiotic effect analysis
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
DK1855550T3 (da) * 2005-02-28 2012-01-16 Nutricia Nv Næringspræparat med probiotika
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
PL1962823T3 (pl) * 2005-12-23 2015-08-31 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka i mangan i/lub molibden do poprawy składu błony komórkowej
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula

Also Published As

Publication number Publication date
CN101951794A (zh) 2011-01-19
WO2009082216A1 (en) 2009-07-02
EP2234505A1 (en) 2010-10-06
WO2009082214A1 (en) 2009-07-02
AR077520A1 (es) 2011-09-07
US20110034407A1 (en) 2011-02-10
RU2608215C2 (ru) 2017-01-17
EP2234505B1 (en) 2013-01-30
PL2589302T3 (pl) 2017-05-31
RU2012155333A (ru) 2014-06-27
EP2229063A1 (en) 2010-09-22
PL2234505T3 (pl) 2013-06-28
ES2402687T3 (es) 2013-05-07
EP2589302A1 (en) 2013-05-08
CN101945589A (zh) 2011-01-12
CN101951794B (zh) 2016-11-02
ES2611203T3 (es) 2017-05-05
EP2589302B1 (en) 2016-11-23
US20110009359A1 (en) 2011-01-13
RU2010130468A (ru) 2012-01-27
RU2478309C2 (ru) 2013-04-10

Similar Documents

Publication Publication Date Title
AR071550A1 (es) Uso de carbohidratos no digeribles para mejorar la microbiota intestinal
Patel Functional food relevance of whey protein: A review of recent findings and scopes ahead
PH12015500904A1 (en) Synbiotics combination for brain improvement
BR112017024777A2 (pt) uso de uma composiçao farmacêutica e de um antibiótico não absorvível para tratamento de transtorno do espectro autista referência cruzada a pedidos relacionados?
JP2010531351A5 (es)
RU2014122168A (ru) Улучшение памяти у пациентов с оценкой 24-26 баллов по краткой шкале оценки психического статуса
AR076070A1 (es) Absorbente de fosfato para el tratamiento de la hiperfosfatemia
US10617700B1 (en) Vitamin supplement compositions with enhanced bioavailability
AR054257A1 (es) Suplemento nutricional para pacientes con hiv
Bhutta Effect of infections and environmental factors on growth and nutritional status in developing countries
NO20055010L (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
RU2002130724A (ru) Питательные модули
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
HRP20160406T1 (hr) Postupci i pripravci za liječenje sa štitnjačom povezanih medicinskih stanja sa sniženiim folatima
ES2547122T3 (es) Composición nutricional de baja concentración
AR098653A1 (es) Composición útil para promover la fertilidad femenina, composición de combinación
Alkholifi et al. Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination
BR112015029947A2 (pt) composições e métodos para liberação de nutriente
Cámara-Martos et al. Enteral nutrition formulas: Current evidence and nutritional composition
ES2935859T3 (es) Composición para mejorar la eficacia de un tratamiento con L-DOPA
HRP20230639T1 (hr) Pripravak koji sadrži lactobacillus reuteri i citrat za medicinsku primjenu
RU2016144680A (ru) Композиция для улучшения умственных способностей
Mayo-Wilson et al. Vitamin A supplementation in Indian children
BR112016005727B1 (pt) Uso de um extrato de polifenol de cacau para preparação de uma composição para tratamento de esofagite eosinofílica
RU2015133249A (ru) Улучшение познавательных способностей недоношенных детей, имеющих низкую массу для своего гестационного возраста

Legal Events

Date Code Title Description
FB Suspension of granting procedure